MAPKAPK3, active, GST tagué humain, PRECISIO Kinase, recombinant, exprimé en cellules baculovirus infectées Sf9, >= 70% (SDS-PAGE), solution aqueuse tamponnée de glycérol

Code: m8322-10ug D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

MAPKAPK3 is closely related to MAPKAPK2 sharing 72% nucleotide and 75% amino acid identity. MAPKAPK3 is activated by growth inducers and stress stimul...


en savoir plus

Votre prix
£455.00 10UG

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

MAPKAPK3 is closely related to MAPKAPK2 sharing 72% nucleotide and 75% amino acid identity. MAPKAPK3 is activated by growth inducers and stress stimulation of cells. In vitro studies demonstrated that ERK, p38 MAP kinase and Jun N-terminal kinase were all able to phosphorylate and activate this kinase, which suggested the role of MAPKAPK3 as an integrative element of signaling in both mitogen and stress responses.

Legal Information

PRECISIO is a registered trademark of Sigma-Aldrich Co. LLC

Physical form

Supplied in 50 mM Tris-HCl, pH 7.5, with 150 mM NaCl, 0.2 5mM DTT, 0.1 mM EGTA, 0.1 mM EDTA, 0.1 mM PMSF, and 25% glycerol.

assay≥70% (SDS-PAGE)
formbuffered aqueous glycerol solution
Gene Informationhuman ... MAPKAPK3(7867)
mol wt~69 kDa
product linePRECISIO® Kinase
Quality Level200
recombinantexpressed in baculovirus infected Sf9 cells
shipped indry ice
specific activity541-731 nmol/min·mg
storage temp.−70°C
UniProt accession no.Q16644
Ce produit répond aux critères suivants: